Why is Andon Health Co., Ltd. ?
1
The company has declared Negative results for the last 13 consecutive quarters
- INTEREST(Q) At CNY 29.75 MM has Grown at 15.02%
- NET PROFIT(Q) At CNY 56.7 MM has Fallen at -46.47%
- DEBT-EQUITY RATIO (HY) Highest at -8.67 %
2
With ROE of 1.24%, it has a very attractive valuation with a 1.43 Price to Book Value
- Over the past year, while the stock has generated a return of 93.14%, its profits have fallen by -72.9%
- At the current price, the company has a high dividend yield of 2.7
3
Market Beating performance in long term as well as near term
- Along with generating 93.14% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Andon Health Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Andon Health Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Andon Health Co., Ltd.
88.66%
1.21
54.30%
China Shanghai Composite
20.18%
1.55
13.83%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.58%
EBIT Growth (5y)
-210.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.09
Tax Ratio
14.26%
Dividend Payout Ratio
31.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
109.99%
ROE (avg)
25.58%
Valuation Key Factors 
Factor
Value
P/E Ratio
116
Industry P/E
Price to Book Value
1.43
EV to EBIT
-80.33
EV to EBITDA
-96.62
EV to Capital Employed
1.48
EV to Sales
25.08
PEG Ratio
NA
Dividend Yield
2.72%
ROCE (Latest)
-1.84%
ROE (Latest)
1.24%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,494.84 MM
ROCE(HY)
Highest at 10.66%
RAW MATERIAL COST(Y)
Fallen by -1.1% (YoY
-31What is not working for the Company
INTEREST(Q)
At CNY 29.75 MM has Grown at 15.02%
NET PROFIT(Q)
At CNY 56.7 MM has Fallen at -46.47%
DEBT-EQUITY RATIO
(HY)
Highest at -8.67 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.61 times
NET SALES(Q)
At CNY 301.48 MM has Fallen at -11.69%
Here's what is working for Andon Health Co., Ltd.
Operating Cash Flow
Highest at CNY 1,494.84 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -1.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Andon Health Co., Ltd.
Interest
At CNY 29.75 MM has Grown at 15.02%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Profit
At CNY 56.7 MM has Fallen at -46.47%
over average net sales of the previous four periods of CNY 105.93 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 301.48 MM has Fallen at -11.69%
over average net sales of the previous four periods of CNY 341.4 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debt-Equity Ratio
Highest at -8.67 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 2.61 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






